Last update 21 Nov 2024

SC-0011

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
FGFRs
Mechanism
FGFRs antagonists(Fibroblast growth factor receptors antagonists)
Therapeutic Areas
NeoplasmsDigestive System DisordersRespiratory Diseases
Active Indication
Advanced gastric carcinomaGastroesophageal junction adenocarcinomaAdvanced Malignant Solid Neoplasm+ [1]
Inactive Indication-
Originator Organization
Shijiazhuang Zhikang Hongren New Drug Development Co., Ltd.Shijiazhuang Zhikang Hongren New Drug Development Co., Ltd.
Active Organization
Shenzhen Lingfang Biomedical Technology Co., Ltd.Shenzhen Lingfang Biomedical Technology Co., Ltd.Shijiazhuang Zhikang Hongren New Drug Development Co., Ltd.Shijiazhuang Zhikang Hongren New Drug Development Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with SC-0011
CTR20233256 / RecruitingPhase 1
一项评价SC0011联合阿帕替尼在晚期胃癌/胃食管结合部腺癌受试者中的安全性、耐受性、有效性的多中心、开放性的Ib期临床研究
[Translation] A multicenter, open-label Phase Ib clinical study to evaluate the safety, tolerability, and efficacy of SC0011 combined with apatinib in subjects with advanced gastric cancer/gastroesophageal junction adenocarcinoma
CTR20210215 / RecruitingPhase 1
一项多中心、开放、单臂、非随机的I 期临床试验：评估泛FGFR 抑制剂SC0011 片在晚期恶性实体瘤患者的安全性、耐受性、药代动力学及药效动力学特征，并初步探索SC0011 片的抗肿瘤活性
[Translation] A multicenter, open, single-arm, non-randomized Phase I clinical trial: To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the pan-FGFR inhibitor SC0011 tablets in patients with advanced malignant solid tumors, and to preliminarily explore the anti-tumor activity of SC0011 tablets
100 Clinical Results associated with SC-0011
Login to view more data
100 Translational Medicine associated with SC-0011
Login to view more data
100 Patents (Medical) associated with SC-0011
Login to view more data
100 Deals associated with SC-0011
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced gastric carcinomaPhase 1
CN
Shenzhen Lingfang Biomedical Technology Co., Ltd.Shenzhen Lingfang Biomedical Technology Co., Ltd.
08 Jan 2024
Gastroesophageal junction adenocarcinomaPhase 1
CN
Shenzhen Lingfang Biomedical Technology Co., Ltd.Shenzhen Lingfang Biomedical Technology Co., Ltd.
08 Jan 2024
Advanced Malignant Solid NeoplasmPhase 1
CN
Shijiazhuang Zhikang Hongren New Drug Development Co., Ltd.Shijiazhuang Zhikang Hongren New Drug Development Co., Ltd.
04 Mar 2021
Locally Advanced Lung Non-Small Cell CarcinomaIND Approval-
Shenzhen Lingfang Biomedical Technology Co., Ltd.Shenzhen Lingfang Biomedical Technology Co., Ltd.
21 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free